Get the Stockscreener App
14.83
3.42%
0.49
After Hours:
15.00
0.17
+1.15%
Meiragtx Holdings Plc stock is traded at $14.83, with a volume of 821.24K.
It is up +3.42% in the last 24 hours and up +26.00% over the past month.
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
See More
Previous Close:
$14.34
Open:
$14.28
24h Volume:
821.24K
Relative Volume:
0.95
Market Cap:
$1.42B
Revenue:
$79.76M
Net Income/Loss:
$-120.53M
P/E Ratio:
-9.9597
EPS:
-1.489
Net Cash Flow:
$3.75M
1W Performance:
+7.70%
1M Performance:
+26.00%
6M Performance:
+92.60%
1Y Performance:
+89.40%
1-Day Range:
$13.72
$14.94
1-Week Range:
$13.53
$15.05
52-Week Range:
$6.62
$15.35
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Name
Meiragtx Holdings Plc
Sector
Industry
Phone
646-860-7985
Address
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
14.83 | 1.40B | 79.76M | -120.53M | 3.75M | -1.489 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | H.C. Wainwright | Buy |
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jul-31-24 | Resumed | Chardan Capital Markets | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Sep-03-19 | Initiated | Piper Jaffray | Overweight |
| Feb-27-19 | Reiterated | Chardan Capital Markets | Buy |
| Jul-03-18 | Initiated | Barclays | Overweight |
| Jul-03-18 | Initiated | BofA/Merrill | Buy |
View All
Meiragtx Holdings Plc Stock (MGTX) Latest News
MeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen - ChartMill
Tocqueville Asset Management L.P. Makes New $1.05 Million Investment in MeiraGTx Holdings PLC $MGTX - MarketBeat
MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $859,320 - Bitget
Meiragtx CEO Forbes sells $859,320 in company stock By Investing.com - Investing.com Australia
Alexandria Forbes Sells 62,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock - MarketBeat
Meiragtx CEO Forbes sells $859,320 in company stock - Investing.com
MeiraGTx (MGTX) holder readies new sale after recent 62K-share cashout - Stock Titan
MeiraGTx (MGTX) CEO sells 62K shares in preset plan at $13.86 - Stock Titan
MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot - vinanet.vn
FY2026 EPS Estimates for MeiraGTx Increased by HC Wainwright - MarketBeat
MeiraGTx (MGTX) Jumps 6.7% to $13.52 as Gene Therapy Pipeline Optimism GrowsWeak Sell Signals - vinanet.vn
Johnson & Johnson Takes $89.72 Billion Position in MeiraGTx Holdings PLC $MGTX - MarketBeat
Price-Driven Insight from (MGTX) for Rule-Based Strategy - Stock Traders Daily
Profit Surge and New Leadership Might Change The Case For Investing In MeiraGTx Holdings (MGTX) - simplywall.st
MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal? - Yahoo Finance
Rubric Capital discloses 9.83% MeiraGTx (MGTX) position totaling 9.1M shares - Stock Titan
MeiraGTx (NASDAQ:MGTX) Trading 8.4% Higher Following Strong Earnings - MarketBeat
MGTX Maintains by RBC Capital -- Price Target Raised to $27.00 - GuruFocus
MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says - marketscreener.com
MeiraGTx (NASDAQ:MGTX) Given New $27.00 Price Target at Royal Bank Of Canada - MarketBeat
MeiraGTx (MGTX) Gains 4.42% as Gene Therapy Focus Draws Investor AttentionETF Inflow Streak - vinanet.vn
RBC Adjusts PT on MeiraGTx to $27 From $26, Maintains Outperform Speculative Risk Rating - marketscreener.com
Sei Investments Co. Buys Shares of 99,627 MeiraGTx Holdings PLC $MGTX - MarketBeat
MeiraGTx (MGTX) Stock Jumps After Profit Shock Raises Durability Questions - Sahm
MeiraGTx (NASDAQ:MGTX) Releases Quarterly Earnings Results, Beats Expectations By $2.17 EPS - MarketBeat
MeiraGTx Holdings Releases Q2 2026 Financial Results - AlphaStreet
Why is MeiraGTx stock surging today? By Investing.com - Investing.com Canada
Why is MeiraGTx stock surging today? - Investing.com
MeiraGTx Holdings plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
MeiraGTx Q2 EPS $1.71 beats $(0.46) estimate; sales up 8.61K% YoY - scanx.trade
MeiraGTx (NASDAQ:MGTX) Shares Gap Up on Strong Earnings - MarketBeat
MeiraGTx earnings beat by $2.02, revenue topped estimates - Investing.com
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
MeiraGTx Reports Second Quarter 2026 Financial and Operational Results - Investing News Network
Form 8K MeiraGTx Holdings PLC For: 13 August By Investing.com - Investing.com South Africa
MeiraGTx Swings to Q2 Profit, Revenue Rises - marketscreener.com
MeiraGTx Holdings plc 2026: Revenue $321.43M, EPS $1.71— 10-Q Summary - TradingView
MeiraGTx (MGTX) turns profitable on $321.7M H1 revenue and major deals - Stock Titan
Form 8K MeiraGTx Holdings PLC For: 13 August - Investing.com India
MeiraGTx reports $321.4M quarterly revenue and $160.7M net income for Q2 2026 - TradingView
Earnings Flash (MGTX) MeiraGTx Holdings plc Reports Q2 Revenue $321,434 - marketscreener.com
MeiraGTx Reports $321.4 Million Revenue and $160.7 Million Quarterly Net Income - Quiver Quantitative
MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
MeiraGTx Q2 FY26 net income swings to USD 160.7 million; revenue jumps to USD 321.4 million - Bitget
MeiraGTx (MGTX) Holds Near $13 as Gene Therapy Pipeline Drives Cautious OptimismHagopian Line - Vinanet
MeiraGTx (MGTX) Steadies at $13.05 as Traders Eye Key Resistance at $13.7Smart Money Flow Stocks - vinanet.vn
MeiraGTx Holdings PLC expected to post a loss of 46 cents a shareEarnings Preview - TradingView
MeiraGTx Holdings PLC (MGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MeiraGTx Holdings PLC (MGTX) Stock News Today - TradingKey
Meiragtx Holdings Plc Stock (MGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
3.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):